Universitätsklinikum Leipzig AöR

2 results · Page 1 of 1

Swipe the table sideways for more columns.

Trial	Conditions	Status	Phase	Updated	More info	NCT ID
A Study Comparing Imetelstat Versus Best Available Therapy for the Treatment of Intermediate-2 or High-risk Myelofibrosis (MF) Who Have Not Responded to Janus Kinase (JAK)-Inhibitor Treatment	Hemic and Lymphatic Diseases, Myeloproliferative Disorders, blood platelet disease, bone marrow disorder, hematologic disorder, polycythemia, primary myelofibrosis, thrombocytosis disease	Active, not recruiting	Phase 3	2026-07-08		NCT04576156
Abbott Vascular Medical Device Registry	Brain Diseases, Metabolic, Brain Diseases, Metabolic, Inborn, Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Nutritional and Metabolic Diseases, X-linked disease, acute myocardial infarction, brain disorder, cardiovascular disorder, central nervous system disorder, coronary artery disorder, coronary restenosis, coronary stenosis, heart disorder, hereditary disease, inborn disorder of amino acid metabolism, inborn errors of metabolism, metabolic disease, myocardial ischemia, nervous system disorder, ornithine carbamoyltransferase deficiency, urea cycle disorder, vascular disorder	Recruiting	Not stated	2025-07-03		NCT04573660

Clinical trials